Predicting Values of Neutrophil-to-Lymphocyte Ratio (NLR), High-Sensitivity C-Reactive Protein (hs-CRP), and Left Atrial Diameter (LAD) in Patients with Nonvalvular Atrial Fibrillation Recurrence After Radiofrequency Ablation

被引:22
作者
Ding, Bing [1 ]
Liu, Pengfei [2 ]
Zhang, Fangfang [1 ]
Hui, Jie [1 ]
He, Linyan [3 ]
机构
[1] Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China
[2] First Peoples Hosp Kunshan, Dept Cardiol, Suzhou, Jiangsu, Peoples R China
[3] Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, NHC Key Lab Thrombosis & Hemostasis,Affiliated Ho, Suzhou, Jiangsu, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2022年 / 28卷
关键词
Atrial Fibrillation; C-Reactive Protein (164-173); Recurrence; CATHETER; IMPACT;
D O I
10.12659/MSM.934569
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The purpose of this study was to evaluate the predictive values of lipid level, inflammatory biomarkers, and echocardiographic parameters in late NVAF (nonvalvular atrial fibrillation) recurrence after RFA (radiofrequen Material/Methods: This retrospective single-center study enrolled 263 patients with paroxysmal or persistent NVAF who underwent initial RFA from Jan 2017 to Jan 2019. The patients were divided into a Recurrent group (n=70) and a Nonrecurrent group (n=193). Univariate and multivariate logistic regression analyses were used for evaluating the predictive factors of late NVAF recurrence. Receiver operating characteristic (ROC) curves were constructed to assess the predictive performance and the optimum cut-off level of variables. Results: Late NVAF recurrence occurred in 70 patients (26.6%) after initial RFA within 12-month follow-up. Patients in the Recurrent group had significant higher NLR (neutrophil-to-lymphocyte ratio), hs-CRP (high-sensitivity C-reactive protein), LVEDD (left ventricular end-diastolic dimension), LVESD (left ventricular end-systolic dimension), and LAD (left atrial diameter) than those in the Nonrecurrent group (P<0.05). In multivariate analysis, increased NLR (HR=1.438, 95% CI: 1.036-1.995, P<0.05), hs-CRP (HR=1.137, 95% CI: 1.029-1.257, P<0.05) and LAD (HR=1.089, 95% CI: 1.036-1.146, P<0.05) were independent predictors of NVAF recurrence. The area under the curve (AUC) of NLR and hs-CRP was 0.603 (95% CI 0.525-0.681) and 0.584 (95% CI 0.501-0.666), respectively. The combination of NLR, hs-CRP, and LAD revealed an AUC of 0.684 (95% CI 0.611-0.757), with cutoff values of 2.33, 2.025 ng/L, and 44.5 mm, respectively. Conclusions: The combination of preoperative NLR, hs-CRP, and LAD can predict late NVAF recurrence.
引用
收藏
页数:7
相关论文
共 27 条
[1]   Relation of Neutrophil to Lymphocyte Ratio to Risk of Incident Atrial Fibrillation [J].
Berkovitch, Anat ;
Younis, Arwa ;
Grossman, Yoni ;
Segev, Shlomo ;
Kivity, Shaye ;
Sidi, Yechezkel ;
Beinart, Roy ;
Goldenberg, Ilan ;
Maor, Elad .
AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (03) :396-401
[2]   Atrial Fibrillation: Pathophysiology and Therapeutic Options [J].
Bhatt, Himani V. ;
Fischer, Gregory W. .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2015, 29 (05) :1333-1340
[3]   Late outcome of surgical radiofrequency ablation for persistent valvular atrial fibrillation in China: a single-center study [J].
Cao, Hailong ;
Xue, Yunxing ;
Zhou, Qing ;
Yu, Minggang ;
Tang, Chenbin ;
Wang, Dongjin .
JOURNAL OF CARDIOTHORACIC SURGERY, 2017, 12
[4]   Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation [J].
Debonnaire, Philippe ;
Joyce, Emer ;
Hiemstra, Yasmine ;
Mertens, Bart J. ;
Atsma, Douwe E. ;
Schalij, Martin J. ;
Bax, Jeroen J. ;
Delgado, Victoria ;
Marsan, Nina Ajmone .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (02)
[5]   Mean platelets volume and neutrophil to lymphocyte ratio as predictors of stroke [J].
Farah, Raymond ;
Samra, Nava .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (01)
[6]   Biomarkers of Atrial Fibrillation in Metabolic Syndrome [J].
Georgakopoulos, Christos ;
Vlachopoulos, Charalambos ;
Tousoulis, Dimitrios .
CURRENT MEDICINAL CHEMISTRY, 2019, 26 (05) :898-908
[7]   Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study [J].
Harrison, Stephanie L. ;
Lane, Deirdre A. ;
Banach, Maciej ;
Mastej, Miroslaw ;
Kasperczyk, Slawomir ;
Jozwiak, Jacek J. ;
Lip, Gregory Y. H. .
ATHEROSCLEROSIS, 2020, 312 :16-22
[8]   Inflammation and the pathogenesis of atrial fibrillation [J].
Hu, Yu-Feng ;
Chen, Yi-Jen ;
Lin, Yenn-Jiang ;
Chen, Shih-Ann .
NATURE REVIEWS CARDIOLOGY, 2015, 12 (04) :230-243
[9]   2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS [J].
Kirchhof, Paulus ;
Benussi, Stefano ;
Kotecha, Dipak ;
Ahlsson, Anders ;
Atar, Dan ;
Casadei, Barbara ;
Castella, Manuel ;
Diener, Hans-Christoph ;
Heidbuchel, Hein ;
Hendriks, Jeroen ;
Hindricks, Gerhard ;
Manolis, Antonis S. ;
Oldgren, Jonas ;
Popescu, Bogdan Alexandru ;
Schotten, Ulrich ;
Van Putte, Bart ;
Vardas, Panagiotis .
EUROPEAN HEART JOURNAL, 2016, 37 (38) :2893-+
[10]   Myocardial injury biomarkers after radiofrequency catheter and cryoballoon ablation for atrial fibrillation and their impact on recurrence [J].
Kizilirmak, Filiz ;
Gokdeniz, Tayyar ;
Gunes, Haci Murat ;
Demir, Gultekin Gunhan ;
Cakal, Beytullah ;
Guler, Gamze Babur ;
Guler, Ekrem ;
Olgun, Fatih Erkam ;
Kilicaslan, Fethi .
KARDIOLOGIA POLSKA, 2017, 75 (02) :126-134